Literature DB >> 18818910

Adjuvant revascularization of intracranial artery occlusion with angioplasty and/or stenting.

Jin Woo Choi1, Jae Kyun Kim, Byung Se Choi, Jeoung Hyun Kim, Hae Jun Hwang, Jong Sung Kim, Sang Joon Kim, Dae Chul Suh.   

Abstract

INTRODUCTION: In conjunction with intravenous and/or intra-arterial thrombolysis, adjuvant revascularization of intracranial artery occlusion by angioplasty vs. stenting remains controversial. We evaluated outcome in patients with intracranial occlusion after angioplasty and/or stenting.
MATERIALS AND METHODS: Thirty-three patients who underwent angioplasty or stenting (17 stenting and 16 angioplasty) for intracranial arterial occlusion during the past 5 years were enrolled from prospective neurointerventional database. We compared recanalization rate [defined as thrombolysis in myocardial infarction (TIMI) grade II/III flow], adverse events, and clinical outcome [modified Rankin scale (mRS) at 1 and 6 months]. We also tried to determine independent variables associated with clinical outcome.
RESULTS: Median initial National Institutes of Health Stroke Scale (NIHSS) was 13 and median time to treatment was 12 h from symptom onset. The successful recanalization rate was mean 79%. Symptomatic hemorrhage occurred in 15% (5/33). Events (27%, 9/33) at 1 month included four deaths, four major, and one minor stroke. Good outcome (mRS <or= 2) was achieved in 17 patients (52%) at 6 months and was significantly related to age, initial NIHSS, TIMI flow, and stenting on bivariate analysis. On multivariable analysis, stenting was the only variable significantly associated with a 6-month, good clinical outcome (OR, 14.48; 95% CI, 1.76 to 118.93; p = 0.013)
CONCLUSION: Intracranial revascularization with angioplasty and/or stenting may improve the clinical outcome in selected patients with intracranial occlusion. Multiple factors are related to favorable clinical outcome.

Entities:  

Mesh:

Year:  2008        PMID: 18818910     DOI: 10.1007/s00234-008-0462-y

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  24 in total

1.  Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.

Authors:  A Furlan; R Higashida; L Wechsler; M Gent; H Rowley; C Kase; M Pessin; A Ahuja; F Callahan; W M Clark; F Silver; F Rivera
Journal:  JAMA       Date:  1999-12-01       Impact factor: 56.272

2.  Self-expanding versus balloon-mounted stents for vessel recanalization following embolic occlusion in the canine model: technical feasibility study.

Authors:  E I Levy; E Sauvageau; R A Hanel; R Parikh; L N Hopkins
Journal:  AJNR Am J Neuroradiol       Date:  2006 Nov-Dec       Impact factor: 3.825

3.  Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study.

Authors:  G W Albers; V E Bates; W M Clark; R Bell; P Verro; S A Hamilton
Journal:  JAMA       Date:  2000-03-01       Impact factor: 56.272

4.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

5.  Interphysician agreement in the diagnosis of subtypes of acute ischemic stroke: implications for clinical trials. The TOAST Investigators.

Authors:  D L Gordon; B H Bendixen; H P Adams; W Clarke; L J Kappelle; R F Woolson
Journal:  Neurology       Date:  1993-05       Impact factor: 9.910

6.  Angioplasty after intra-arterial thrombolysis for acute occlusion of intracranial arteries.

Authors:  T Ueda; S Sakaki; I Nochide; Y Kumon; K Kohno; S Ohta
Journal:  Stroke       Date:  1998-12       Impact factor: 7.914

7.  Predictors of hyperacute clinical worsening in ischemic stroke patients receiving thrombolytic therapy.

Authors:  Richard Leigh; Osama O Zaidat; Muhammad F Suri; Gwendolyn Lynch; Sophia Sundararajan; Jeffrey L Sunshine; Robert Tarr; Warren Selman; Dennis M D Landis; Jose I Suarez
Journal:  Stroke       Date:  2004-06-03       Impact factor: 7.914

8.  Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

Authors:  W Hacke; M Kaste; C Fieschi; R von Kummer; A Davalos; D Meier; V Larrue; E Bluhmki; S Davis; G Donnan; D Schneider; E Diez-Tejedor; P Trouillas
Journal:  Lancet       Date:  1998-10-17       Impact factor: 79.321

9.  Prognostic factors for neurologic outcome after endovascular revascularization of acute symptomatic occlusion of the internal carotid artery.

Authors:  D C Suh; J K Kim; C G Choi; S J Kim; H W Pyun; C Ahn; D H Yang; K S Lim; J-G Leem; K D Hahm; J-H Lee; S U Kwon; J S Kim
Journal:  AJNR Am J Neuroradiol       Date:  2007 Jun-Jul       Impact factor: 3.825

10.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

View more
  7 in total

1.  Computational flow dynamics of the severe m1 stenosis before and after stenting.

Authors:  Dae Chul Suh; Young Bae Ko; Sung-Tae Park; Kyunghwan Yoon; Ok Kyun Lim; Jin Sun Oh; Yun Gyeong Jeong; Jong Sung Kim
Journal:  Neurointervention       Date:  2011-02-28

2.  High shear stress at the surface of enhancing plaque in the systolic phase is related to the symptom presentation of severe M1 stenosis.

Authors:  Dae Chul Suh; Sung-Tae Park; Tack Sun Oh; Sang-Ok Park; Ok Kyun Lim; Soonchan Park; Chang Woo Ryu; Deok Hee Lee; Young Bae Ko; Sang-Wook Lee; Kyunghwan Yoon; Jong Sung Kim
Journal:  Korean J Radiol       Date:  2011-07-22       Impact factor: 3.500

3.  Intracranial stenting for severe symptomatic stenosis: self-expandable versus balloon-expandable stents.

Authors:  Soonchan Park; Jae-Hyuk Kim; Jae Kyun Kwak; Hye Jin Baek; Bo Hyun Kim; Dong-Geun Lee; Deok Hee Lee; Jong Sung Kim; Dae Chul Suh
Journal:  Interv Neuroradiol       Date:  2013-09-26       Impact factor: 1.610

4.  The outcome and efficacy of recanalization in patients with acute internal carotid artery occlusion.

Authors:  J H Kwak; L Zhao; J K Kim; S Park; D-G Lee; J H Shim; D H Lee; J S Kim; D C Suh
Journal:  AJNR Am J Neuroradiol       Date:  2013-10-03       Impact factor: 3.825

5.  Computational modeling with fluid-structure interaction of the severe m1 stenosis before and after stenting.

Authors:  Soonchan Park; Sang-Wook Lee; Ok Kyun Lim; Inki Min; Minhtuan Nguyen; Young Bae Ko; Kyunghwan Yoon; Dae Chul Suh
Journal:  Neurointervention       Date:  2013-02-28

6.  Outpatient (Same-day care) Neuroangiography and Neurointervention.

Authors:  Yun-Gyeong Jeong; Eun Hye Kim; Sun Moon Hwang; Ga Young Lee; Jong Woo Kim; Yeong Jun Choi; Jae-Hyuk Kwak; Dae Chul Suh
Journal:  Neurointervention       Date:  2012-02-29

7.  A Study Design to Evaluate Association between Smoking and Intracranial Atherosclerotic Stenosis.

Authors:  Hairi Liu; Dong-Geun Lee; Seung Chul Jung; Hyun Jung Koo; Eun Hye Kim; Seon Moon Hwang; Bum Joon Kim; Yeonjung Kim; Hong Jun Cho; Min-Ju Kim; Seung Hee Baek; Sang-Beom Jeon; Jong Sung Kim; Dae Chul Suh
Journal:  Neurointervention       Date:  2014-09-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.